Skip to content
Research Article Open access CC BY 4.0

Epidemiology of Hepatitis B Virus Infection in South-South, Nigeria: A Review

C. F. Umego, C. I. Mboto, E. N. Mbim, U. O. Edet, U. E. George, J. E. Tarh

International STD Research & Reviews · pp. 1–17 · Published 8 Feb 2018

10.9734/ISRR/2018/36989

Abstract

Hepatitis B virus (HBV) is a small enveloped DNA virus of the Hepadnaviridae family associated with infection of the liver, and a major public health problem globally. The virus preferentially infects the liver leading to hepatic complications such as hepatic carcinoma and liver cirrhosis. About two billion people globally have been estimated to be infected with hepatitis B virus and approximately 350-400 million others reportedly suffer from the chronic forms. An estimated two million of these carriers die each year as a result of complications. The mode of transmission of the disease is largely through unprotected sex, mother-to-child transmission (MTCT), contaminated blood and blood products and use of contaminated sharp objects or instruments. Africa is a high endemic area with 7–26% prevalence rate of HBsAg. Nigeria has been placed among the group of countries endemic for HBV infection with about 18 million infected. In recent years, the rates of prevalence of HBV have been increasing within the South-South part of the country. Serological and molecular techniques are currently employed not only in the diagnosis of this infection but also to assess the prognosis of the disease, guide therapy and monitor treatment responses. Treatment is highly supportive and two major groups of antiviral treatment licensed for the treatment of chronic HBV infection are pegylated interferon alpha and nucleoside or nucleotide analogues. Interrupting early transmission is key to breaking the cycle of ongoing HBV infection. In addition to active vaccination, the implementation of blood safety strategies including quality-assured screening of all donated blood and components used for transfusion may prevent transmission of HBV to a significant level.  

HBV epidemiology prevalence South-South Nigeria

References (57)

  1. 1 The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide [DOI]
  2. 2 Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews [DOI]
  3. 3 Hepatitis B: The virus and disease # [DOI]
  4. 4 Molecular biology of hepatitis B virus infection [DOI]
  5. 5 Synthesis and assembly of hepatitis B virus surface antigen particles in yeast [DOI]
  6. 6 The natural history of chronic hepatitis B virus infection # [DOI]
  7. 7 Control of cccDNA function in hepatitis B virus infection [DOI]
  8. 8 Hepatitis B virus replication [DOI]
  9. 9 Hepatitis B epidemiology in Asia, the Middle East and Africa [DOI]
  10. 10 Medical Virology of Hepatitis B: how it began and where we are now [DOI]
  11. 11 HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C [DOI]
  12. 12 Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: A systematic review and meta-analysis [DOI]
  13. 13 Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar Es Salaam, Tanzania [DOI]
  14. 14 Enhancement of Hepatitis B Virus Replication by the Regulatory X Protein In Vitro and In Vivo [DOI]
  15. 15 The Laboratory Diagnosis of Hepatitis B Virus [DOI]
  16. 16 Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study [DOI]
  17. 17 The replication cycle of hepatitis B virus [DOI]
  18. 18 Prevalence, sociodemographic features and risk factors of Hepatitis B virus infection among pregnant women in Southwestern Nigeria [DOI]
  19. 19 Hepatitis B virus genes and their expression in E. coli [DOI]
  20. 20 Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription [DOI]
  21. 21 DNA of a Human Hepatitis B Virus Candidate [DOI]
  22. 22 Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria [DOI]
  23. 23 Cloned HBV DNA causes hepatitis in chimpanzees [DOI]
  24. 24 THE TRANSMISSION DYNAMICS AND CONTROL OF HEPATITIS B VIRUS IN THE GAMBIA [DOI]
  25. 25 Intracellular transport of hepatitis B virus [DOI]
  26. 26 High levels of hepatitis B virus DNA in body fluids from chronic carriers [DOI]
  27. 27 Biosynthesis of hepatitis B virus surface antigen in Escherichia coli [DOI]
  28. 28 Hepatitis b virus (hbv) infection among pregnant women in makurdi, nigeria. [DOI]
  29. 29 Prevalence of Hepatitis B virus markers in surgeons in Lagos, Nigeria [DOI]
  30. 30 Hepatitis B virus infection in Indonesia [DOI]
  31. 31 Prevalence of hepatitis B virus infection among pregnant women in an antenatal clinic in Port Harcourt, Nigeria [DOI]
  32. 32 Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients [DOI]
  33. 33 Seroprevalence of Hepatitis B Surface Antigen and Antibody among Pregnant Women Attending a Tertiary Health Institution in Southwestern Nigeria [DOI]
  34. 34 Epidemiology of Hepatitis B in Canada [DOI]
  35. 35 Epidemiology of Hepatitis B infection among pregnant women in Minna, Nigeria [DOI]
  36. 36 Detection of hepatitis B virus core antigen by phage display mediated TaqMan real-time immuno-PCR [DOI]
  37. 37 Co-infections of hepatitis B and C with human immunodeficiency virus among adult patients attending human immunodeficiency virus outpatients clinic in Benin City, Nigeria [DOI]
  38. 38 Unraveling the complexity of hepatitis B virus: From molecular understanding to therapeutic strategy in 50 years [DOI]
  39. 39 Seroprevalence of human immunodeficiency virus, Hepatitis b, Hepatitis c, syphilis and co-infections among antenatal women in a tertiary institution in south-east Nigeria [DOI]
  40. 40 Serological markers of hepatitis B infection in infants presenting for their first immunization
  41. 41 Hepatitis B surface antigenaemia in Ilorin, Kwara State, Nigeria.
  42. 42 Patterns of HIV infection among native and refugee Afghans [DOI]
  43. 43 A comparison of molecular methods for hepatitis B virus (HBV) DNA detection from oral fluid samples [DOI]
  44. 44 Sero-prevalence of Hepatitis B Surface Antigen (HBsAg) amongst Pregnant Women Attending Antenatal Clinic at the Federal Medical Centre Umuahia, Abia State, Nigeria [DOI]
  45. 45 Prevalence of the Hepatitis B “e” Antigen in Nigerian Patients with Chronic Liver Disease [DOI]
  46. 46 Hepatitis B Virus Seroprevalence and Serology Patterns in a Cohort of HIV Positive Individuals from Harare, Zimbabwe [DOI]
  47. 47 Prevalence of Hepatitis B Surface Antigen among Residents of Julius Berger Staff Quarters, Kubwa, Abuja
  48. 48 Prevalence of Hepatitis B virus infection amongst parturients in the University of Ilorin Teaching Hospital
  49. 49 Hepatitis B Virus (HBV) Infection among Alcoholic Consumers at a Local Community, North-East Nigeria
  50. 50 Clinical uses of HBV-DNA assays [DOI]
  51. 51 Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region [DOI]
  52. 52 Hepatitis B virus burden in developing countries [DOI]
  53. 53 Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China [DOI]
  54. 54 Seroprevalence of hepatitis B virus serological markers among pregnant Nigerian women [DOI]
  55. 55 Infection Counter: Automated Quantification of in Vitro Virus Replication by Fluorescence Microscopy [DOI]
  56. 56 Seroprevalence Of Hepatitis B Surface Antigen Among Prospective Blood Donors In An Urban Area Of Benue State [DOI]
  57. 57 Seroprevalence of Hepatitis B Surface Antigen among Pregnant Women Attending Ante-Natal Clinics in Sokoto Metropolis [DOI]

Cited by 20

Community Pharmacists Role on Hepatitis B Vaccination and Immunization in Nigeria

Nneoma N. Okpalanma, Chisom MC Chukwulokwu, Nnedimma E Okoli · 2025

Prevalence of human immunodeficiency, hepatitis B and hepatitis C viruses among antenatal care attendees in Bauchi State, Nigeria

Dada Mansur Mustapha, Danladi Elizabeth Saba’atu, Yusuf Abdu Misau · Annals of African Medical Research · 2019

Hepatitis B virus infection in Nigeria: a systematic review and meta-analysis of data published between 2010 and 2019

Busayo I. Ajuwon, Isabelle Yujuico, Katrina Roper · BMC Infectious Diseases · 2021

Data on information sources, knowledge and practice on hepatitis B virus in southwest Nigeria

Evaristus Adesina, Olusola Oyero, Nelson Okorie · Data in Brief · 2020

Health Communication and Behavioural Practice towards Ending Hepatitis B Virus in Southwest Nigeria

Evaristus Adesina, Davies Adeloye, Hezekiah Falola · The Scientific World Journal · 2020

Assessment of health communication practice on hepatitis B in Southwest Nigeria

Evaristus Adesina, Olusola Oyero, Nelson Okorie · Cogent Social Sciences · 2020

Showing 8 of 20 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

68

Page views

0

PDF downloads

6

Outbound clicks

20

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.